Tight control decision-making during T cell-vascular endothelial cell interaction

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Firner, Sonja ^a   Onder, Lucas ^a   Nindl, Veronika ^a   Ludewig, Burkhard ^a  

^a Institute of Immunobiology   (Switzerland)

Author keywords

Costimulation; High endothelial venules; Inflammation; Transplantation

Indexed keywords

EID: 84873386568     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00279     Document Type: Article

References (61)

1. Pober, J. S. (2008). Endothelial cells inallograftrejection. Transplantation 86,1340-1348.
2. Anderson, A. O., and Anderson, N. D. (1976). Lymphocyte emigration from high endothelial venules in rat lymph nodes. Immunology 31, 731-748.
3. Ansel, K. M., Ngo, V. N., Hyman, P. L., Luther, S. A., Forster, R., Sedgwick, J. D., Browning, J.L., Lipp, M.,andCyster, J. G. (2000). A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309-314.
4. Bannerman, D. D., Tupper, J. C., Ricketts, W. A., Bennett, C. F., Winn, R. K., and Harlan, J .M. (2001).A constitutive cytoprotective path-way protects endothelial cells from lipopolysaccharide-induced apopto-sis. J. Biol. Chem. 276, 1492414932.
5. Barber, D. L., Wherry, E. J., Maso-pust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., and Ahmed, R. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687.
6. Bechmann, I., Galea, I., and Perry, V. H. (2007). What is the blood-brain barrier (not)? Trends Immunol. 28, 5-11.
7. Biedermann, B. C., Sahner, S., Gregor, M., Tsakiris, D. A., Jeanneret, C., Pober, J. S., and Gratwohl, A. (2002). Endothelial injury mediatedbycytotoxicTlymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 359, 2078-2083.
8. Blum, K. S., and Pabst, R. (2006). Keystones in lymph node development. J. Anat. 209, 585-595.
9. Bolinger, B., Engeler, D., Krebs, P., Miller, S., Firner, S., Hoffmann, M., Palmer, D. C., Restifo, N. P., Tian, Y., Clavien, P. A., and Ludewig, B. (2010). IFN-gamma-receptor signalingamelioratestransplantvasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells. Eur. J. Immunol. 40, 733-743.
10. Bolinger, B., Krebs, P., Tian, Y., Engeler, D., Scandella, E., Miller, S., Palmer, D. C., Restifo, N. P., Clavien, P. A., and Ludewig, B. (2008). Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen. Blood 111, 4588-4595.
11. Buchner, K., Henn, V., Grafe, M., de Boer, O.J., Becker, A.E.,and Kroczek, R. A. (2003). CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40CD40L signalling in atherosclerosis. J. Pathol. 201,288-295.
12. Buettner, M., and Bode, U. (2011). Lymph node transplantation and its immunological significance in animal models. Clin. Dev. Immunol. 2011,353510.
13. Cailhier, J. F., Laplante, P., and Hebert, M. J. (2006). Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. Am. J. Transplant. 6, 247-253.
14. Carman, C. V., Sage, P. T., Sciuto, T. E., delaFuente, M.A., Geha, R.S., Ochs, H. D., Dvorak, H. F., Dvorak, A. M., and Springer, T. A. (2007). Transcellulardiapedesisisinitiatedbyinvasive podosomes. Immunity 26, 784-797.
15. Cecka, J. M. (2010). HLA matching for organ transplantation...why not? Int. J. Immunogenet. 37,323-327.
16. Celli, S., Albert, M. L., and Bousso, P. (2011). Visualizing the innate and adaptive immune responses underlying allograft rejection by twophoton microscopy. Nat. Med. 17, 744-749.
17. Cohen, J. N., Guidi, C. J., Tewalt, E. F., Qiao, H., Rouhani, S. J., Ruddell, A., Farr, A. G., Tung, K. S., and Engelhard, V. H. (2010). Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J. Exp. Med. 207, 681-688.
18. Crispe, I. N. (2009). The liver as a lymphoid organ. Annu. Rev. Immunol. 27,147-163.
19. Danese, S., Dejana, E., and Fiocchi, C. (2007). Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J. Immunol. 178,6017-6022.
20. Dejana, E., Tournier-Lasserve, E., and Weinstein, B. M. (2009). The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 16,209-221.
21. Dengler, T. J., and Pober, J. S. (2000). Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J. Immunol. 164, 5146-5155
22. Domigan, C. K., and Iruela-Arispe, M. L. (2012). Recent advances in vascular development. Curr. Opin. Hematol. 19, 176-183.
23. Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N.W., Witzenrath, M., Rosseau, S., Suttorp, N., Sobke, A., Herrmann, M., Preissner, K. T., Vajkoczy, P., and Augustin, H. G. (2006). Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat. Med. 12,235-239.
24. Fletcher, A. L., Lukacs-Kornek, V., Reynoso, E. D., Pinner, S. E., Bellemare-Pelletier, A., Curry, M. S., Collier, A. R., Boyd, R. L.,and Turley, S. J. (2010). Lymph node fibroblastic reticularcellsdirectlypresentperipheral tissue antigen under steady-state and inflammatory conditions. J. Exp. Med. 207,689-697.
25. Gardner, J. M., Devoss, J. J., Friedman, R. S., Wong, D. J., Tan, Y. X., Zhou, X., Johannes, K. P., Su, M. A., Chang, H. Y., Krummel, M. F., and Anderson, M. S. (2008). Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321, 843-847.
26. Gkaliagkousi, E., Douma, S., Zamboulis, C., and Ferro, A. (2009). Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. J. Hypertens. 27,2310-2320.
27. Grabie, N., Gotsman, I., DaCosta, R., Pang, H., Stavrakis, G., Butte, M. J., Keir, M. E., Freeman, G. J., Sharpe, A. H., and Lichtman, A. H. (2007). Endothelial program meddeath-1ligand 1 (PD-L1) regulates CD8+ T-cell mediatedinjuryintheheart. Circulation 116,2062-2071.
28. Hayasaka, H., Taniguchi, K., Fukai, S., and Miyasaka, M. (2010). Neogenesis and development of the high endothelialvenulesthatmediatelymphocyte trafficking. Cancer Sci. 101, 2302-2308.
29. Heeger, P. S. (2003). T-cell allorecognition and transplant rejection: a summary and update. Am. J. Transplant. 3,525-533.
30. Henn, V., Slupsky, J.R., Grafe, M., Anagnostopoulos, I., Forster, R., MullerBerghaus, G., and Kroczek, R. A. (1998). CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391,591-594.
31. Hesser, B. A., Liang, X. H., Camenisch, G., Yang, S., Lewin, D.A., Scheller, R., Ferrara, N., and Gerber, H. P. (2004). Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood 104, 149-158.
32. Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T., and Honjo, T. (2003). PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 198,39-50.
33. Junt, T., Scandella, E., and Ludewig, B. (2008). Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat. Rev. Immunol. 8, 764-775.
34. Kreisel, D., Krupnick, A. S., Gelman, A. E., Engels, F.H., Popma, S.H., Krasinskas, A. M., Balsara, K. R., Szeto, W. Y., Turka, L. A., and Rosengard, B. R. (2002). Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternativemechanismof allorecognition. Nat. Med. 8,233-239.
35. Kumar, V., Scandella, E., Danuser, R., Onder, L., Nitschke, M., Fukui, Y., Halin, C., Ludewig, B., and Stein, J. V. (2010). Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood 115, 4725-4733.
36. Kummer, M., Lev, A., Reiter, Y., and Biedermann, B. C. (2005). Vascular endothelial cells have impaired capacity to present immunodominant, antigenic peptides: a mechanism of cell type-specific immune escape. J. Immunol. 174,1947-1953.
37. Lakkis, F. G., Arakelov, A., Konieczny, B. T., and Inoue, Y. (2000). Immunologic'ignorance'ofvascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6,686-688.
38. Laubli, H., Spanaus, K. S., and Borsig, L.(2009).Selectin-mediatedactivation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes. Blood 114, 4583-4591.
39. Lemichez, E., Lecuit, M., Nassif, X., and Bourdoulous, S. (2010). Breaking the wall: targeting of the endothelium by pathogenic bacteria. Nat. Rev. Microbiol. 8,93-104.
40. Libby, P., and Pober, J. S. (2001). Chronic rejection. Immunity 14, 387-397.
41. London, N. R., Zhu, W., Bozza, F. A., Smith, M. C., Greif, D. M., Sorensen, L.K., Chen, L., Kaminoh, Y., Chan, A. C., Passi, S. F., Day, C. W., Barnard, D. L., Zimmerman, G. A., Krasnow, M. A., and Li, D. Y. (2010). Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci. Transl. Med. 2, 23ra19.
42. Mempel, T. R., Junt, T., and von Andrian, U. H. (2006). Rulers over randomness: stroma cells guide lymphocyte migration in lymph nodes. Immunity 25, 867-869.
43. Minami, T., Yano, K., Miura, M., Kobayashi, M., Suehiro, J., Reid, P. C., Hamakubo, T., Ryeom, S., Aird, W. C., and Kodama, T. (2009). The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice. J. Clin. Invest. 119,2257-2270.
44. Miura, A., Honma, R., Togashi, T., Yanagisawa, Y., Ito, E., Imai, J., Isogai, T., Goshima, N., Watanabe, S., and Nomura, N. (2006). Differential responsesofnormalhumancoronary artery endothelial cells against multiple cytokines comparatively assessed by gene expression profiles. FEBS Lett. 580, 6871-6879.
45. Mueller, S. N., Matloubian, M., Clemens, D. M., Sharpe, A. H., Freeman, G. J., Gangappa, S., Larsen, C. P., and Ahmed, R. (2007). Viral targeting of fibroblastic reticular cells contributes to immunosuppressionandpersistenceduringchronicinfection. Proc. Natl. Acad. Sci. U.S.A. 104, 15430-15435.
46. Murphy, T. L., and Murphy, K. M. (2010). Slowdownandsurvive:enigmatic immunoregulation by BTLA and HVEM. Annu. Rev. Immunol. 28, 389-411.
47. Paolillo, R., Iovene, M. R., Romano, C. C., and Rizzo, A. (2012). Induction of VEGF and MMP-9 expression by TOLL-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae. Int. J. Immunopathol. Pharmacol. 25, 377-386.
48. Pober, J. S., and Sessa, W. C. (2007). Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7,803-815.
49. Pober, J. S., and Tellides, G. (2012). Participation of blood vessel cells in human adaptive immune responses. Trends Immunol. 33, 49-57.
50. Roozendaal, R., and Mebius, R. E. (2011). Stromal cell-immune cell interactions.Annu.Rev.Immunol.29, 23-43.
51. Sage, P. T., Varghese, L. M., Martinelli, R., Sciuto, T. E., Kamei, M., Dvorak, A. M., Springer, T. A., Sharpe, A. H., and Carman, C. V.(2012). Antigen recognition is facilitatedbyinvadosome-likeprotrusions formedbymemory/effectorTcells. J. Immunol. 188,3686-3699.
52. Scandella, E., Bolinger, B., Lattmann, E., Miller, S., Favre, S., Littman, D. R., Finke, D., Luther, S. A., Junt, T., and Ludewig, B. (2008). Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat. Immunol. 9, 667-675.
53. Schlaeger, T. M., Bartunkova, S., Lawitts, J. A., Teichmann, G., Risau, W., Deutsch, U., and Sato, T. N. (1997). Uniform vascularendothelial-cell-specific gene expression in both embryonic and adult transgenicmice. Proc. Natl.Acad. Sci. U.S.A. 94, 3058-3063.
54. Sigmundsdottir, H., and Butcher, E. C. (2008). Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat. Immunol. 9, 981-987.
55. Slupsky, J. R., Kalbas, M., Willuweit, A., Henn, V., Kroczek, R. A., and Muller-Berghaus, G. (1998). Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb. Haemost. 80, 1008-1014.
56. Spencer, C. T., Gilchuk, P., Dragovic, S. M., and Joyce, S. (2010). Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand. Curr. Opin. Organ Transplant. 15, 512-525.
57. Turley, S. J., Fletcher, A. L., and Elpek, K. G. (2010). The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat. Rev. Immunol. 10, 813-825.
58. van de Pavert, S. A., and Mebius, R. E. (2010). New insights into the development of lymphoid tissues. Nat. Rev. Immunol. 10, 664-674.
59. van Hinsbergh, V. W. (2012). Endothelium role in regulation of coagulation and inflammation. Semin. Immunopathol. 34,93-106.
60. Wang, X., Li, H., Matte-Martone, C., Cui, W., Li, N., Tan, H.S., Roopenian, D., and Shlomchik, W. D. (2011). Mechanisms of antigen presentation to T cells in murine graft-versushost disease: cross-presentation and theappearanceofcross-presentation. Blood 118, 6426-6437.
61. Zecher, D., and Lakkis, F. G. (2008). Ignorance is bliss. Blood 111, 44264427.